About AI Patient Communication & Engagement
The AI Patient Communication & Engagement category is part of the AI Clinical Documentation & Ambient Medicine market map, tracking 14 companies building in this segment. Ambient AI scribes, autonomous medical coding, clinical decision support, and patient engagement platforms reducing documentation burden and improving care quality across health systems. Curated by Hartmann Capital's venture research team.
Companies in AI Patient Communication & Engagement
- Hyro — Growth, $95M
- Hippocratic AI — Series C, $404M
- Notable Health — Series B, $119M
- Syllable — Series C, $82M
- Memora Health — Acquired, $80M
- Tennr — Series C, $162M
- Tendo — Series B, $69M
- Aiva Health — Seed
- Artera — Growth, $65M
- Luma Health — Series C, $160M
- Hello Patient — Series A, $23M
- Popai Health — Seed, $11M
- Counsel Health — Seed, $11M
- Insight Health — Seed
Frequently Asked Questions
- What companies are in the AI Patient Communication & Engagement category?
- The AI Patient Communication & Engagement category includes 14 companies: Hyro, Hippocratic AI, Notable Health, Syllable, Memora Health, Tennr, Tendo, Aiva Health, Artera, Luma Health, Hello Patient, Popai Health, Counsel Health, Insight Health. This is part of the AI Clinical Documentation & Ambient Medicine market map maintained by Hartmann Capital.
- How many AI Patient Communication & Engagement startups are tracked?
- Hartmann Capital tracks 14 companies in the AI Patient Communication & Engagement segment of the AI Clinical Documentation & Ambient Medicine market map.
- What are the best funded AI Patient Communication & Engagement companies?
- Top funded companies in AI Patient Communication & Engagement include Hippocratic AI ($404M), Tennr ($162M), Luma Health ($160M), Notable Health ($119M), Hyro ($95M). Browse the full list in the AI Clinical Documentation & Ambient Medicine market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.